American Society of Hematology

Hematologic Drug Shortage Information


Updated on: May 10, 2016

ASH continues to work with Congress, federal agencies, and other stakeholders to ensure continued access to safe and effective hematologic drugs.

New Updates on Hematologic Drug Shortages

National Shortage of Bleomycin

 ASH was recently alerted to the national shortage of Bleomycin and has been in communication with the FDA about this shortage.  ASH will continue to monitor this shortage and provide real-time updates to ASH members as they become available.  The Society will also continue to encourage the FDA to do everything within their authority to mitigate the situation.  If you have questions or are experiencing issues accessing Bleomycin, please contact the individual companies for emergency supply. 

  • Fresenius Kabi USA, LLC 888-386-1300
  • Hospira, Inc. 877-946-7747
  • Teva Pharmaceuticals 800-545-8800

If you continue to experience issues accessing Bleomycin, please contact the FDA at drugshortages@fda.hhs.gov or by phone at 301-796-3400. For more information or to notify ASH on other drug shortages, please contact Katherine Stark at kstark@hematology.org.

 

back to top

Current Hematologic Drug Shortages

back to top

Recently Resolved Hematologic Drug Shortages

back to top

Additional Resources

back to top

ASH's Comments to Congress and the U.S. Food and Drug Administration

back to top

Media Coverage of Drug Shortages

back to top